Thromboelastography in obese horses with insulin dysregulation compared to healthy controls.
dc.citation.issue | 3 | |
dc.citation.volume | 36 | |
dc.contributor.author | Lovett AL | |
dc.contributor.author | Gilliam LL | |
dc.contributor.author | Sykes BW | |
dc.contributor.author | McFarlane D | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-08-14T20:12:55Z | |
dc.date.available | 2024-08-14T20:12:55Z | |
dc.date.issued | 2022-05-01 | |
dc.description.abstract | BACKGROUND: Both obesity and metabolic syndrome are associated with hypercoagulability in people, increasing the risk of cardiovascular disease and thromboembolic events. Whether hypercoagulability exists in obese, insulin-dysregulated horses is unknown. HYPOTHESIS/OBJECTIVES: To determine if coagulation profiles differ between healthy horses and those with obesity and insulin dysregulation. ANIMALS: Fifteen healthy horses (CON) and 15 obese, insulin-dysregulated horses (OBID). Individuals were university or client owned. METHODS: Case-control study. Obesity was defined as a body condition score (BCS) ≥7.5/9 (modified Henneke scale). Insulin dysregulation status was assessed by an oral sugar test (OST). Kaolin-thromboelastography and traditional coagulation variables were compared between groups. The direction and strength of the association between coagulation variables and BCS and OST results were determined using Spearman's correlation. RESULTS: Thromboelastography variables MA (OBID: 69.5 ± 4.5 mm; CON: 64.8 ± 4.3 mm; P = .007) and G-value (OBID: 11749 ± 2536 dyn/m2 ; CON: 9319 ± 1650 dyn/m2 ; P = .004) were higher in OBID compared to CON. Positive correlations between MA and BCS (R = 0.45, P = .01) and serum insulin (T0 : R = 0.45, P = .01; T60 : R = 0.39, P = .03), and G-value and BCS (R = 0.46, P = .01), and serum insulin (T0 : R = 0.48, P = .007; T60 : R = 0.43, P = .02; T90 : R = 0.38, P = .04) were present. CONCLUSIONS AND CLINICAL IMPORTANCE: Obese, insulin-dysregulated horses are hypercoagulable compared to healthy controls. | |
dc.description.confidential | false | |
dc.edition.edition | May 2022 | |
dc.format.pagination | 1131-1138 | |
dc.identifier.author-url | https://www.ncbi.nlm.nih.gov/pubmed/35429197 | |
dc.identifier.citation | Lovett AL, Gilliam LL, Sykes BW, McFarlane D. (2022). Thromboelastography in obese horses with insulin dysregulation compared to healthy controls.. J Vet Intern Med. 36. 3. (pp. 1131-1138). | |
dc.identifier.doi | 10.1111/jvim.16421 | |
dc.identifier.eissn | 1939-1676 | |
dc.identifier.elements-type | journal-article | |
dc.identifier.issn | 0891-6640 | |
dc.identifier.uri | https://mro.massey.ac.nz/handle/10179/71293 | |
dc.language | eng | |
dc.publisher | John Wiley and Sons, Inc. | |
dc.publisher.uri | https://onlinelibrary.wiley.com/doi/10.1111/jvim.16421 | |
dc.relation.isPartOf | J Vet Intern Med | |
dc.rights | (c) 2022 The Author/s | |
dc.rights | CC BY-NC-ND 4.0 | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | equine metabolic syndrome | |
dc.subject | hemostasis | |
dc.subject | hypercoagulability | |
dc.subject | obesity | |
dc.subject | oral sugar test | |
dc.subject | viscoelastic testing | |
dc.subject | Animals | |
dc.subject | Case-Control Studies | |
dc.subject | Horse Diseases | |
dc.subject | Horses | |
dc.subject | Humans | |
dc.subject | Insulin | |
dc.subject | Obesity | |
dc.subject | Thrombelastography | |
dc.subject | Thrombophilia | |
dc.title | Thromboelastography in obese horses with insulin dysregulation compared to healthy controls. | |
dc.type | Journal article | |
pubs.elements-id | 452938 | |
pubs.organisational-group | Other |